Oragenics Inc (OGEN)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $893,370
Last updated: Nov 17, 2026 at 4:27 PM ET
Oragenics Inc (OGEN) Stock Chart
Oragenics (OGEN) has a latest price of $0.21 on Nov 17, 2026, 81.1% below its 52-week high of $1.11. Its price fell 81.3% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 62.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $12,587.44 in Jan 2017 and its lowest $0.37 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart OGEN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OGEN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 60.4%, and over 6 months it fell 63.4%. The month-end price fell 99.7% over the 3 years through Oct 2026, a compound annual decline of 84.9%.
| Period | Change |
|---|---|
| 1 month | -50.2% |
| 3 months | -60.4% |
| 6 months | -63.4% |
| 12 months | -81.3% |
| 12 months, with dividends | -81.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -99.7% | -84.9% |
| 5 years | -100.0% | -80.0% |
| 10 years | -100.0% | -62.9% |
Price by Year
Its best calendar year was 2021, when the price fell 0.7%, and its weakest was 2024, when it fell 93.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.37 | -52.2% |
| 2025 | $0.78 | -92.9% |
| 2024 | $11.09 | -93.4% |
| 2023 | $168.96 | -10.6% |
| 2022 | $188.99 | -76.4% |
| 2021 | $802.00 | -0.7% |
| 2020 | $807.39 | -13.7% |
| 2019 | $935.07 | -39.5% |
| 2018 | $1,544.30 | -62.7% |
| 2017 | $4,135.87 | -57.4% |
Trading Range
The price is 50.7% below its 50-day average of $0.43 and 63.4% below its 200-day average of $0.57.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.21 | |
| 52-week high | $1.11 | -81.1% |
| 52-week low | $0.17 | +23.5% |
| 50-day average | $0.43 | -50.7% |
| 200-day average | $0.57 | -63.4% |
Price Risk
Over 3 years, its largest fall from a peak was 99.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.27 |
| Largest fall, 1 year | -82.2% |
| Largest fall, 3 years | -99.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About OGEN
What is OGEN's 1-year price change?
Oragenics's price fell 81.3% over the past 12 months. With dividends included, the 12-month total return was -81.3%.
What is OGEN's 5-year price change?
Oragenics's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 80.0%. These figures leave out dividends.
What is OGEN's 52-week high and low?
Oragenics's 52-week high is $1.11 and its 52-week low is $0.17. Its latest price of $0.21 on Nov 17, 2026 is 81.1% below the high.
What is OGEN's beta?
Oragenics's 1-year beta against the S&P 500 is 1.27, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 82.2%.
Is the OGEN chart free?
Yes. Advanced Charting for OGEN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
OGEN pages: Overview, Charting, Earnings, Financials, Statistics, Competitors